Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Sono-Tek
SOTK
$82.8M
| $557K | ﹤0.01% |
153,025
+27,670
| +22% | +$106K |
|
3502
Central Plains Bancshares
CPBI
$86.1M
| $556K | ﹤0.01% |
37,290
+2,584
| +7% | +$38.1K |
|
3503
FibroBiologics
FBLG
$6.5M
| $553K | ﹤0.01% |
30,732
+486
| +2% | +$13.9K |
|
3504
LanzaTech
LNZA
$69.8M
| $553K | ﹤0.01% |
22,847
+255
| +1% | +$22.9K |
|
3505
374Water
SCWO
$37.6M
| $552K | ﹤0.01% |
162,336
+6,327
| +4% | +$28K |
|
3506
Mastech Digital
MHH
$93.2M
| $550K | ﹤0.01% |
53,876
+2,492
| +5% | +$30.4K |
|
3507
Comstock
LODE
$245M
| $547K | ﹤0.01% |
223,988
+29,719
| +15% | +$98.7K |
|
3508
CytomX Therapeutics
CTMX
$754M
| $546K | ﹤0.01% |
857,958
+42,315
| +5% | +$32.8K |
|
3509
FitLife Brands
FTLF
$94.2M
| $546K | ﹤0.01% |
45,056
-1,348
| -3% | -$20K |
|
3510
PepGen
PEPG
$197M
| $540K | ﹤0.01% |
383,893
+11,038
| +3% | +$22.7K |
|
3511
Auburn National Bancorp
AUBN
$91.9M
| $539K | ﹤0.01% |
24,968
+1,600
| +7% | +$34.4K |
|
3512
Gain Therapeutics
GANX
$77.6M
| $539K | ﹤0.01% |
282,211
+14,790
| +6% | +$32.8K |
|
|
WW
3513
DELISTED
WW International
WW
| $537K | ﹤0.01% |
1,026,524
+41,507
| +4% | +$36.1K |
|
|
BLDP
3514
Ballard Power Systems
BLDP
$790M
| $536K | ﹤0.01% |
486,467
+194,565
| +67% | +$274K |
|
3515
ADS-TEC Energy
ADSE
$889M
| $534K | ﹤0.01% |
35,572
| – | – |
|
3516
NSTS Bancorp
NSTS
$66.7M
| $531K | ﹤0.01% |
47,044
+6,304
| +15% | +$76.4K |
|
3517
Rapid Micro Biosystems
RPID
$86.2M
| $531K | ﹤0.01% |
200,936
+47,824
| +31% | +$109K |
|
3518
Outlook Therapeutics
OTLK
$191M
| $529K | ﹤0.01% |
433,853
+86,624
| +25% | +$152K |
|
|
HSAI
3519
Hesai Group
HSAI
$3.02B
| $529K | ﹤0.01% |
35,768
-11,932
| -25% | -$203K |
|
3520
Genmab
GMAB
$19.5B
| $529K | ﹤0.01% |
27,016
-16,695
| -38% | -$350K |
|
3521
MIND Technology
MIND
$46.2M
| $528K | ﹤0.01% |
88,032
+1,785
| +2% | +$14.3K |
|
3522
Quince Therapeutics
QNCX
$29.5M
| $526K | ﹤0.01% |
1,979
+99
| +5% | +$30.2K |
|
3523
Biodesix
BDSX
$248M
| $526K | ﹤0.01% |
42,061
+701
| +2% | +$13.5K |
|
3524
Tevogen Inc. Common Stock
TVGN
$27.3M
| $525K | ﹤0.01% |
9,728
+691
| +8% | +$45.5K |
|
3525
Fuel Tech
FTEK
$43.7M
| $525K | ﹤0.01% |
499,892
+29,077
| +6% | +$28.9K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 122 new positions and adding to 3,780 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 122 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.